Richmar TheraTouch CX2 Professional Series Combo 2-Channel Stimulator + Ultrasound

Richmar TheraTouch CX2 2-Channel Combination Stimulator + Ultrasound

• Electrotherapy waveform rationale
• Appropriate parameter settings
• Electrode placement guide
• Ultrasound applicator recommendations

A few simple key presses are all that is needed to quick-start a treatment. Parameters can be easily selected and adjusted. Clinicians can choose to use preset clinical protocols or customize their own. The “Favorites” feature allows user-defined protocols to be stored for future use.

The two electrotherapy channels can be used in combination with ultrasound, or totally independent, with different protocols running simultaneously. The ergonomically designed 5 cm² sound head provides for an excellent ERA.

• Interferential (Premodulated 2-Pole & Traditional 4-Pole)
• TENS (Biphasic)
• Neuromuscular Stimulation (EMS/NMS)
• Russian Stim
• High Volt Pulsed Current (HVPC)
• Microcurrent
• Therapeutic Ultrasound
• *NEW* RAAS (Rapid Agonist & Antagonist Sequencing)
  

In addition, the TheraTouch CX2 offers a comprehensive library with treatment education and suggested electrode placement for better treatment outcome and improved clinic efficiency.

Features:

• Combination electrotherapy and ultrasound therapy system
• 2 channels of independent stimulation can be used in combination (linked) or totally independent
• Multi-patient function provides the ability to treat up to 2 patients at once for maximum practice usage
• Independent intensity and parameter controls for each channel
• Sleek, user-friendly, ergonomic design for table top or therapy cart use
• Large, easy-to-read, color LCD display with touch screen interface
• Multiple waveform electrotherapy with six clinical waveform modalities
  
• Clinical protocols providing the appropriate parameters for a variety of acute and chronic conditions
• Manual operation allows for user-defined protocols
• “Favorites” feature allows storage of up to 99 custom programs for future use
• Comprehensive library provides treatment education and suggested electrode placement
• Patient Remote Kill Switch connection allows patient to stop treatment at the push of a button
• 1 and 3 MHz ultrasound frequencies
• Pulsed and Continuous ultrasonic output modes
• Ergonomically designed 5 cm² sound head for excellent ERA during treatments (1 cm² sound head optional)
• Low BNR ratio of 5:1
• Ultrasound Amplitude can be toggled between w and w/cm²
• Sound head coupling feature
• Optional therapy cart (Part #: DQCART-2), sold separately, integrates with the unit and keeps supplies organized and ready for treatments
  

Technical Specifications:

• Number of Channels: 2, Isolated
• Treatment Time: 1-60 min, adjustable
• Power Supply: 100-240 VAC, 50-60 Hz
• Dimensions (LxWxH): ~ 12” x 8” x 10”
• Weight: 6 lbs.

WARNING: CANCER & REPRODUCTIVE HARM; PROP 65 WARNING INFO

Proposition 65 requires businesses to provide warnings to Californians about significant exposures to chemicals that cause cancer, birth defects or other reproductive harm. These chemicals can be in the products that Californians purchase, in their homes or workplaces, or th??at are released into the environment. By requiring that this information be provided, Proposition 65 enables Californians to make informed decisions about their exposures to these chemicals.

Are any businesses exempt from Proposition 65’s requirements?

YES. Businesses with less than 10 employees and government agencies are exempt from Proposition 65’s warning requirements and prohibition on discharges into drinking water sources.  Tartan Group is exempt from Proposition 65 requirements as our business has fewer than 10 employees, however, we feel that it is important to warn CA residents of the possibility that some of our products may contain chemicals that cause cancer, birth defects or other reproductive harm.

More Specific Information about Businesses and Proposition 65:

https://oehha.ca.gov/proposition-65/businesses-and-proposition-65

Proposition 65 also prohibits California businesses from knowingly discharging significant amounts of listed chemicals into sources of drinking water.

Proposition 65 requires California to publish a list of chemicals known to cause cancer, birth defects or other reproductive harm. This list, which must be updated at least once a year, has grown to include approximately 900 chemicals since it was first published in 1987.

Proposition 65 became law in November 1986, when California voters approved it by a 63-37 percent margin. The official name of Proposition 65 is the Safe Drinking Water and Toxic Enforcement Act of 1986.

For More General Information About Proposition 65, please click the link below:

https://oehha.ca.gov/proposition-65